Ateroid: for treating cerebral circulation

Cerebral Aging

The nervous system ages: in an 80 years old man the weight of the brain is reduced by an average of 15%. The reduction in weight typically begins after age 50 and it is determined by the apparent decrease in the number of neurons and glial cells.
In humans, the contents of hippocampal neurons decrease about 10% every 10 years in the second half of life.
In addition, the blood circulation system of the brain cells, which has the task of providing nutrients for cell metabolism (glucose and oxygen) and to maintain efficient blood-brain barrier, shows changes associated with aging and the blood-brain barrier may deteriorate allowing the passage of harmful substances and contribute to neuronal loss.


In order to face an aging brain, the therapeutic intervention should focus not only on protecting neurons, but also on allowing for efficient micro-circulation by protecting the endothelium.

In other words, when it comes to brain function decline, you should always consider both the nervous aspect and the vascular one.

There is also evidence that oxidative stress alters cell membranes of neurons and endothelial cells, causing excessive coarctation of proteoglycans that are extremely abundant on the membranes. Any antioxidant treatment is therefore protective, as small glycosaminoglycans (sulfomucopolysaccharides) that cross the blood-brain membrane may be able to do.


50 capsules box.

6 vials box.


Vascular diseases with thrombotic risk.

Active ingredient

24 mg of polysulphurized glycosaminoglycans (1 capsule).

30 mg of polysulphurized glycosaminoglycans (1 vial).

Recommended dose

2-3 capsules per day (away from meals).

1-2 vials intramuscularly per day.